← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Avery Dennison grew sales slightly, but cash flow, margins, and leverage moved the other way.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +1.1% to $8.86BNote
- Profitability — Net income -2.4% to $0.69BWatch
- Cash quality — FCF -2.4% to $0.71BWatch
- Margins — Gross margin -15 bps; net margin -28 bpsWatch
- Capital — Buybacks +131.2%; debt +25.4%Watch
- Accounting — No manipulation flag; Z grey zoneNote
Business
Avery Dennison is a materials science and digital identification company. It sells pressure-sensitive label materials, graphics and reflective films, tapes, RFID inlays and tags, branding materials, pricing and shelf-edge media, and software that connects physical items to digital data.
Where the revenue comes from
Fiscal 2025, as Avery Dennison Corp reports it. History and quarterly detail are in the app.
- Materials Group$6.1B
- Solutions Group$2.8B
Leadership changes
From Avery Dennison Corp's own filings, the day they're filed.
- Ward Dickson · director · appointmenteff. 2024-06-01
- Maria Fernanda Mejia · director · appointmenteff. 2024-02-22
- David Flitman · director · appointment
Latest filings
- 8-K · Company announcement2026-08-19
- 10-Q · Quarterly report2026-08-04
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-06-04
- 10-Q · Quarterly report2026-05-05
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Avery Dennison Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.